http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017116150-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d4220d217bf8b61aa5bf84e483519be
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2016-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fda7ffd86ff21361315b6a59b63333e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9eb94e4ca14f0215c02fea4d2b48650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b05ddb3cab4c2abc22195f2978bceb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c54336b310cfdf2ca31abb6ee0035ce5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93e2b56cd198ecc87a8b66c4dae735d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5031a40ca0eee539145b5a64d3ce07ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d75c9f7344b02683bdac026a42757a06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dde26869d10c44b703c2aadec8b20de1
publicationDate 2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017116150-A1
titleOfInvention Pharmaceutical composite preparation
abstract The present invention relates to a tablet which contains, as active ingredients, candesartan or candesartan cilexetil and amlodipine or a pharmaceutically acceptable salt thereof, and which uses a specific solubilizing agent in order to significantly improve the stability and elution of the active ingredient. In addition, the present invention relates to a method for preparing the tablet.
priorityDate 2015-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101302883-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100048137-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070085801-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110085307-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425535208
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23669624
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454611257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21993177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409203328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534378
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID59272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426249326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60496

Total number of triples: 56.